Literature DB >> 8956572

Image subtraction in gadolinium-enhanced MR imaging.

V S Lee1, M A Flyer, J C Weinreb, G A Krinsky, N M Rofsky.   

Abstract

Image subtraction in gadolinium-enhanced MR imaging is a broadly applicable postprocessing technique that can be used with any field strength and T1-weighted sequence. This technique is typically a quick and efficient means of obtaining fat suppression that avoids the limitations of incomplete fat saturation due to field inhomogeneity and increased imaging times associated with conventional fat-suppression techniques. In particular, image subtraction may be valuable on lower strength magnetic field systems that lack effective chemical-shift fat-suppression techniques. Because source data are viewed in conjunction with subtracted images, image subtraction is unlikely to introduce errors in interpretation. By performing unenhanced and enhanced sequences in a manner amenable to image subtraction, radiologists should find this technique to be a useful and almost cost-free option.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8956572     DOI: 10.2214/ajr.167.6.8956572

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  13 in total

Review 1.  MR angiography of the intracranial vessels: technical aspects and clinical applications.

Authors:  Ozkan Ozsarlak; Johan W Van Goethem; Menno Maes; Paul M Parizel
Journal:  Neuroradiology       Date:  2004-12-04       Impact factor: 2.804

Review 2.  Modern cross-sectional imaging in the diagnosis and follow-up of intracranial aneurysms.

Authors:  Karsten Papke; Friedhelm Brassel
Journal:  Eur Radiol       Date:  2006-01-14       Impact factor: 5.315

3.  Emerging techniques and technologies in brain tumor imaging.

Authors:  Benjamin M Ellingson; Martin Bendszus; A Gregory Sorensen; Whitney B Pope
Journal:  Neuro Oncol       Date:  2014-10       Impact factor: 12.300

4.  Characterizing and eliminating errors in enhancement and subtraction artifacts in dynamic contrast-enhanced breast MRI: Chemical shift artifact of the third kind.

Authors:  Jamal J Derakhshan; Elizabeth S McDonald; Evan S Siegelman; Mitchell D Schnall; Felix W Wehrli
Journal:  Magn Reson Med       Date:  2017-08-24       Impact factor: 4.668

5.  Consensus recommendations on standardized magnetic resonance imaging protocols for multicenter canine brain tumor clinical trials.

Authors:  Rebecca A Packer; John H Rossmeisl; Michael S Kent; John F Griffin; Christina Mazcko; Amy K LeBlanc
Journal:  Vet Radiol Ultrasound       Date:  2018-03-09       Impact factor: 1.363

6.  Is there a need for contrast-enhanced T1-weighted MRI of the spine after inconspicuous short tau inversion recovery imaging?

Authors:  Andreas H Mahnken; Joachim E Wildberger; Gerhard Adam; Sven Stanzel; Thomas Schmitz-Rode; Rolf W Günther; Arno Buecker
Journal:  Eur Radiol       Date:  2005-03-18       Impact factor: 5.315

7.  Quantitative contrast ratio comparison between T1 (TSE at 1.5T, FLAIR at 3T), magnetization prepared rapid gradient echo and subtraction imaging at 1.5T and 3T.

Authors:  Richard Keith Downs; Mariah Haider Bashir; Chin Kau Ng; Jens Olaf Heidenreich
Journal:  Quant Imaging Med Surg       Date:  2013-06

8.  Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma.

Authors:  Benjamin M Ellingson; Lauren E Abrey; Sarah J Nelson; Timothy J Kaufmann; Josep Garcia; Olivier Chinot; Frank Saran; Ryo Nishikawa; Roger Henriksson; Warren P Mason; Wolfgang Wick; Nicholas Butowski; Keith L Ligon; Elizabeth R Gerstner; Howard Colman; John de Groot; Susan Chang; Ingo Mellinghoff; Robert J Young; Brian M Alexander; Rivka Colen; Jennie W Taylor; Isabel Arrillaga-Romany; Arnav Mehta; Raymond Y Huang; Whitney B Pope; David Reardon; Tracy Batchelor; Michael Prados; Evanthia Galanis; Patrick Y Wen; Timothy F Cloughesy
Journal:  Neuro Oncol       Date:  2018-08-02       Impact factor: 12.300

9.  Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo.

Authors:  Benjamin M Ellingson; Lauren E Abrey; Josep Garcia; Olivier Chinot; Wolfgang Wick; Frank Saran; Ryo Nishikawa; Roger Henriksson; Warren P Mason; Robert J Harris; Kevin Leu; Davis C Woodworth; Arnav Mehta; Catalina Raymond; Ararat Chakhoyan; Whitney B Pope; Timothy F Cloughesy
Journal:  Neuro Oncol       Date:  2018-10-09       Impact factor: 12.300

10.  New MRI series for kidney evaluation: Saving time and money.

Authors:  Matteo Renzulli; Stefano Brocchi; Irene Pettinari; Maurizio Biselli; Alfredo Clemente; Beniamino Corcioni; Salvatore Cappabianca; Caterina Gaudiano; Rita Golfieri
Journal:  Br J Radiol       Date:  2019-06-12       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.